UA817A1 - Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів - Google Patents

Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів

Info

Publication number
UA817A1
UA817A1 UA3646751A UA3646751A UA817A1 UA 817 A1 UA817 A1 UA 817A1 UA 3646751 A UA3646751 A UA 3646751A UA 3646751 A UA3646751 A UA 3646751A UA 817 A1 UA817 A1 UA 817A1
Authority
UA
Ukraine
Prior art keywords
compounds
alkylene
alkyl
independently
general formula
Prior art date
Application number
UA3646751A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Шьон Уве
Хахмайстер Берг
Кербах Вольфган
Кюль Ульріх
Бушманн Герд
Original Assignee
Калі - Хемі Фарма Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Калі - Хемі Фарма Гмбх filed Critical Калі - Хемі Фарма Гмбх
Publication of UA817A1 publication Critical patent/UA817A1/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UA3646751A 1982-09-18 1983-09-16 Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів UA817A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane

Publications (1)

Publication Number Publication Date
UA817A1 true UA817A1 (uk) 1993-12-15

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
UA3646751A UA817A1 (uk) 1982-09-18 1983-09-16 Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів

Country Status (25)

Country Link
US (2) US4550112A (en, 2012)
EP (2) EP0250903B1 (en, 2012)
JP (2) JPS5970686A (en, 2012)
AT (2) ATE69817T1 (en, 2012)
AU (1) AU564910B2 (en, 2012)
CA (1) CA1254209A (en, 2012)
CS (1) CS389891A3 (en, 2012)
DD (1) DD213923A5 (en, 2012)
DE (3) DE3234697A1 (en, 2012)
DK (1) DK165833C (en, 2012)
ES (1) ES525653A0 (en, 2012)
FI (1) FI76338C (en, 2012)
GE (1) GEP19960316B (en, 2012)
GR (1) GR78722B (en, 2012)
HU (1) HU191096B (en, 2012)
IE (1) IE57580B1 (en, 2012)
IL (1) IL69751A (en, 2012)
MX (1) MX9202996A (en, 2012)
NO (1) NO160516C (en, 2012)
NZ (1) NZ205627A (en, 2012)
PH (1) PH20768A (en, 2012)
PT (1) PT77344B (en, 2012)
SU (1) SU1272989A3 (en, 2012)
UA (1) UA817A1 (en, 2012)
ZA (1) ZA836185B (en, 2012)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
RU2228934C1 (ru) * 2003-05-20 2004-05-20 ООО "Исследовательский институт химического разнообразия" Замещенные 3,7-диазобицикло[3.3.1]нонаны, фокусированная библиотека и комбинаторная библиотека
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005011690A1 (en) * 2003-07-21 2005-02-10 Solvay Pharmaceuticals Gmbh Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CA2609938A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (en, 2012) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
FI76338C (fi) 1988-10-10
IE57580B1 (en) 1993-01-13
NO160516B (no) 1989-01-16
PT77344A (en) 1983-10-01
DE3234697A1 (de) 1984-03-22
JPH05247039A (ja) 1993-09-24
ZA836185B (en) 1984-04-25
EP0250903A3 (en) 1988-03-09
ES8405398A1 (es) 1984-06-01
PH20768A (en) 1987-04-10
GEP19960316B (en) 1996-06-24
MX9202996A (es) 1992-07-01
HU191096B (en) 1987-01-28
NO160516C (no) 1989-04-26
PT77344B (en) 1986-03-11
CA1254209A (en) 1989-05-16
EP0103833A3 (en) 1984-11-28
GR78722B (en, 2012) 1984-10-02
DE3382466D1 (de) 1992-01-09
SU1272989A3 (ru) 1986-11-23
DK422583A (da) 1984-03-19
IE832186L (en) 1984-03-18
IL69751A0 (en) 1983-12-30
DK165833B (da) 1993-01-25
AU1920683A (en) 1984-03-22
DD213923A5 (de) 1984-09-26
JPS5970686A (ja) 1984-04-21
DK422583D0 (da) 1983-09-16
EP0103833B1 (de) 1989-08-16
ATE45579T1 (de) 1989-09-15
IL69751A (en) 1986-10-31
CA1259998C (en, 2012) 1989-09-26
EP0250903A2 (de) 1988-01-07
EP0103833A2 (de) 1984-03-28
DE3380409D1 (de) 1989-09-21
NO833346L (no) 1984-03-19
FI833339A0 (fi) 1983-09-19
FI76338B (fi) 1988-06-30
US4742172A (en) 1988-05-03
FI833339L (fi) 1984-03-19
DK165833C (da) 1993-06-21
US4550112A (en) 1985-10-29
NZ205627A (en) 1985-11-08
JPH0670056B2 (ja) 1994-09-07
ATE69817T1 (de) 1991-12-15
AU564910B2 (en) 1987-09-03
EP0250903B1 (de) 1991-11-27
CS389891A3 (en) 1992-07-15
ES525653A0 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
UA817A1 (uk) Спосіб одержання діазабіцикло - (3, 3, 1) - нонанів
GB1488601A (en) Pyrazolopyridopyrimidine derivatives
DE3160036D1 (en) Substituted imidazoles, their preparation and pharmaceutical compositions containing the same
GR860413B (en) Process for the preparation of alkene alkyne or cycloalkylene derivatives
ES8200108A1 (es) Un procedimiento para la preparacion de derivados de tioxan tina.
ES8700253A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil- -2-piperazinoalquilpirazolin-3-ona
ES452550A1 (es) Procedimiento para la preparacion de derivadas de acidos fe-noxialcohilcarboxilicos.
ES449939A1 (es) Procedimiento para preparar sulfuro de difenilo sustituido.
ES445661A1 (es) Procedimiento para la preparacion de derivados de acetileno.
DE3273219D1 (en) Novel alkane and alkene derivatives and their preparation and use
KR850001207A (ko) 수용성 리팜피신 유도체의 제조방법
ES427115A1 (es) Procedimiento de preparacion de nuevos derivados del acido acetico.
ES466192A1 (es) Procedimiento para la obtencion de derivados de la isoqui- noleina.
GB1519742A (en) Solvent compositons
GR79151B (en, 2012)
CA1246072A (en) ISOCYANATO-AZETIDINEDIONES
HUT34942A (en) Process for the production of new 4-hydroxy -benzhydrols, as well as of therapeutic preparations contaning them
ES459401A1 (es) Un procedimiento para la produccion de nuevos compuestos 6, 11-dihidrodibenzo b.e.tiepin- -11-ona
GB1488904A (en) X-ray contrast media
ES2001420A6 (es) Procedimiento para la preparacion de derivados de naftaleno.
ES466032A1 (es) Procedimiento para la preparacion de derivados de alcohil- teofilina, sustituidos con radicales basicos.
ES8307250A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclohepta (1,2-b) pirrol.
GEP19970814B (en) Composition for fuel
JO921B1 (en) Process to produce substituted basic alkyl theophylline
ES445300A1 (es) Un procedimiento para la preparacion de nuevos derivados de xantina.